News | April 09, 2026
Insmed’s Brensocatib fails to hit endpoints in hidradenitis suppurativa study
The results were consistent across both the 10 mg and 40 mg treatment arms
The results were consistent across both the 10 mg and 40 mg treatment arms
The new capital is expected to fund the company through 2029
New adult supplement combines 26 vitamins, minerals and botanicals to address stress, energy, immunity and cognitive wellness in one daily tablet
New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network
AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17
TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners
Opioid dependence remains a major driver of death and disease worldwide
Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules
The data will be presented at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, April 17-21
Subscribe To Our Newsletter & Stay Updated
